Ausgabe 4/2018
Inhalt (15 Artikel)
Do you know how to get the J-START quality assurance guideline?
Takayoshi Uematsu, Seigo Nakamura, Noriaki Ohuchi
The long and winding road for overcoming resistance to hormone therapy in breast cancer
Shigehira Saji
Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications
Toru Hanamura, Shin-ichi Hayashi
Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer
Kazuhiro Araki, Yasuo Miyoshi
Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial
N. Masuda, M. Toi, N. Yamamoto, H. Iwata, K. Kuroi, H. Bando, S. Ohtani, T. Takano, K. Inoue, Y. Yanagita, H. Kasai, S. Morita, T. Sakurai, S. Ohno
Clinical utility of RT-PCR in assessing HER 2 gene expression versus traditional IHC and FISH in breast cancer patients
Moushumi Suryavanshi, Anurag Mehta, Jiten Jaipuria, Dushyant Kumar, Gayatri Vishwakarma, Manoj Kumar Panigrahi, Haristuti Verma, Mumtaz Saifi, Sanjeev Sharma, Simran Tandon, D. C. Doval, Bhudev C. Das
Correlation of FANCM expression with clinical factors in luminal B breast cancer
Yiran Wang, Junnan Wang, Fei Long, Ning Wang, Bingbing Zhang, Huan Han, Yajie Wang
Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)
Shoichiro Ohtani, Takahiro Nakayama, Tetsuhiro Yoshinami, Ken-ichi Watanabe, Fumikata Hara, Yasuaki Sagara, Hidetoshi Kawaguchi, Kenji Higaki, Nobuki Matsunami, Yoshie Hasegawa, Masato Takahashi, Makiko Mizutani, Takashi Morimoto, Masako Sato, Mitsuya Itoh, Satoshi Morita, Norikazu Masuda
OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer
Jia-Ming Zhang, Kai Wei, Ming Jiang
Preoperative breast MRI: reproducibility and significance of findings relevant to nipple–areolar complex involvement
Youichi Machida, Akiko Shimauchi, Takao Igarashi, Kazuei Hoshi, Eisuke Fukuma
Meta-analysis for psychological impact of breast reconstruction in patients with breast cancer
Wanjing Chen, Xiaoai Lv, Xiaohong Xu, Xiufei Gao, Bei Wang
Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors
Michiyo Saimura, Kenichiro Koga, Keisei Anan, Shoshu Mitsuyama, Sadafumi Tamiya
Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials
Allan Ramos-Esquivel, Hellen Hernández-Steller, Marie-France Savard, Denis Ulises Landaverde
Effect of the normal mammary differentiation regulator ELF5 upon clinical outcomes of triple negative breast cancers patients
Fumiya Omata, Keely May McNamara, Koyu Suzuki, Eriko Abe, Hisashi Hirakawa, Takanori Ishida, Noriaki Ohuchi, Hironobu Sasano